Reaction Details |
![](/images/Email.png) | Report a problem with these data |
Target | Wee1-like protein kinase |
---|
Ligand | BDBM518526 |
---|
Substrate/Competitor | n/a |
---|
Meas. Tech. | ChEMBL_2134694 (CHEMBL4844304) |
---|
IC50 | 2.4±n/a nM |
---|
Citation | Huang, PQ; Boren, BC; Hegde, SG; Liu, H; Unni, AK; Abraham, S; Hopkins, CD; Paliwal, S; Samatar, AA; Li, J; Bunker, KD Discovery of ZN-c3, a Highly Potent and Selective Wee1 Inhibitor Undergoing Evaluation in Clinical Trials for the Treatment of Cancer. J Med Chem64:13004-13024 (2021) [PubMed] Article |
---|
More Info.: | Get all data from this article, Assay Method |
---|
|
Wee1-like protein kinase |
---|
Name: | Wee1-like protein kinase |
Synonyms: | Serine/threonine-protein kinase WEE1 | WEE1 | WEE1 homolog (S. pombe) | WEE1_HUMAN |
Type: | PROTEIN |
Mol. Mass.: | 71599.12 |
Organism: | Homo sapiens (Human) |
Description: | ChEMBL_1445054 |
Residue: | 646 |
Sequence: | MSFLSRQQPPPPRRAGAACTLRQKLIFSPCSDCEEEEEEEEEEGSGHSTGEDSAFQEPDS
PLPPARSPTEPGPERRRSPGPAPGSPGELEEDLLLPGACPGADEAGGGAEGDSWEEEGFG
SSSPVKSPAAPYFLGSSFSPVRCGGPGDASPRGCGARRAGEGRRSPRPDHPGTPPHKTFR
KLRLFDTPHTPKSLLSKARGIDSSSVKLRGSSLFMDTEKSGKREFDVRQTPQVNINPFTP
DSLLLHSSGQCRRRKRTYWNDSCGEDMEASDYELEDETRPAKRITITESNMKSRYTTEFH
ELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVV
RYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM
SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQVEEGDS
RFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQWHEIRQGRLPRIPQVLSQ
EFTELLKVMIHPDPERRPSAMALVKHSVLLSASRKSAEQLRIELNAEKFKNSLLQKELKK
AQMAKAAAEERALFTDRMATRSTTQSNRTSRLIGKKMNRSVSLTIY
|
|
|
BDBM518526 |
---|
n/a |
---|
Name | BDBM518526 |
Synonyms: | 2-Allyl-1-(6-(2-hydroxypropan-2-yl)pyridin-2-yl)-6-((2′-methyl-2′,3′-dihydro-1′H-spiro-[cyclopropane-1,4′-isoquinolin]-7′-yl)amino)-1,2-dihydro-3H-pyrazolo[3,4-d]pyrimidin-3-one | US11124518, Example 1 |
Type | Small organic molecule |
Emp. Form. | C28H31N7O2 |
Mol. Mass. | 497.5914 |
SMILES | CN1Cc2cc(Nc3ncc4c(n3)n(-c3cccc(n3)C(C)(C)O)n(CC=C)c4=O)ccc2C2(CC2)C1 |
Structure |
|